Video: Empowering Researchers to Unlock New Innovations

I think we have some really exciting developments in our instrument capabilities. What that will mean is that the applications available to customers are only going to grow. And that will give great new options in the cell and gene therapy area. But also in the in the markets and the applications that we already are very established in. For example, the manufacturing and development of monoclonal antibodies, another protein-based therapies, as well as our Ella platform that allows various immuno-oncology applications and monitoring. Really there's a huge range of opportunities in the next few years. It's a really exciting time. What motivates me is the science. You know I'm a scientist by background. And the opportunities for us to help customers, researchers to develop new therapies, new treatments that improve health care. That's really what drives and excites me every day.